Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands

Journal of Steroid Biochemistry and Molecular Biology

Volumn 89-90, Issue , 2004, Pages 437-441

  Adorini, Luciano ^a   Penna, Giuseppe ^a   Giarratana, Nadia ^a   Roncari, Andrea ^a   Amuchastegui, Susana ^a   Daniel, Kenn C ^a   Uskokovic, Milan ^b  

^a BioXell SpA   (Italy)

^b Bioxell Inc   (United States)

Author keywords

APC; Dendritic cell; VDR

Indexed keywords

20 EPICALCITRIOL; CALCITRIOL; CALCITRIOL DERIVATIVE; CHEMOKINE RECEPTOR CCR4; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TRANSCRIPTION FACTOR NFAT; VITAMIN D RECEPTOR;

ADOPTIVE TRANSFER; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; CONFERENCE PAPER; DENDRITIC CELL; DRUG EFFICACY; DRUG POTENCY; EXPERIMENTAL INFECTION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERCALCEMIA; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; LIGAND BINDING; MAXIMUM TOLERATED DOSE; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TARGET CELL; TISSUE SPECIFICITY;

DENDRITIC CELLS; RECEPTORS, CALCITRIOL;

EID: 3042550031     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.03.013     Document Type: Conference Paper

References (48)

1. Deluca H.F., Cantorna M.T. Vitamin D: its role and uses in immunology. Faseb J. 15(14):2001;2579-2585
2. Mathieu C., Adorini L. The coming of age of 1, 25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol. Med. 8(4):2002;174-179
3. Adorini L. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int. Immunopharmacol. 2(7):2002;1017-1028
4. Carlberg C., Polly P. Gene regulation by vitamin D3. Crit. Rev. Eukaryot. Gene Expr. 8(1):1998;19-42
5. Provvedini D.M., Tsoukas C.D., Deftos L.J., Manolagas S.C. 12, 5-dihydroxyvitamin D3 receptors in human leukocytes. Science. 221(4616):1983;1181-1183
6. Brennan A., Katz D.R., Nunn J.D., Barker S., Hewison M., Fraher L.J., O'Riordan J.L. Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology. 61(4):1987;457-461
7. Veldman C.M., Cantorna M.T., DeLuca H.F. Expression of 1, 25-dihydroxyvitamin D(3) receptor in the immune system. Arch. Biochem. Biophys. 374(2):2000;334-338
8. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:2000;767-811
9. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392(6673):1998;245-252
10. Jonuleit H., Schmitt E., Schuler G., Knop J., Enk A.H. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192(9):2000;1213-1222
11. Penna G., Adorini L. 1, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164:2000;2405-2411
12. Piemonti L., Monti P., Sironi M., Fraticelli P., Leone B.E., Dal Cin E., Allavena P., Di Carlo V. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 164(9):2000;4443-4451
13. Griffin M.D., Lutz W.H., Phan V.A., Bachman L.A., McKean D.J., Kumar R. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem. Biophys. Res. Commun. 270(3):2000;701-708
14. Berer A., Stockl J., Majdic O., Wagner T., Kollars M., Lechner K., Geissler K., Oehler L. 1, 25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp. Hematol. 28(5):2000;575-583
15. Canning M.O., Grotenhuis K., de Wit H., Ruwhof C., Drexhage H.A. 1-alpha, 25-Dihydroxyvitamin D3 (1, 25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur. J. Endocrinol. 145(3):2001;351-357
16. van Halteren A.G., van Etten E., de Jong E.C., Bouillon R., Roep B.O., Mathieu C. Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1, 25 dihydroxyvitamin D(3). Diabetes. 51(7):2002;2119-2125
17. Chang C.C., Ciubotariu R., Manavalan J.S., Yuan J., Colovai A.I., Piazza F., Lederman S., Colonna M., Cortesini R., Dalla-Favera R., Suciu-Foca N. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3(3):2002;237-243
18. Hewison M., Freeman L., Hughes S.V., Evans K.N., Bland R., Eliopoulos A.G., Kilby M.D., Moss P.A., Chakraverty R. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 170(11):2003;5382-5390
19. Griffin M.D., Lutz W., Phan V.A., Bachman L.A., McKean D.J., Kumar R. Dendritic cell modulation by 1alpha, 25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 22:2001;22
20. Gregori S., Casorati M., Amuchastegui S., Smiroldo S., Davalli A.M., Adorini L. Regulatory T cells induced by 1α, 25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167:2001;1945-1953
21. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2(6):2002;389-400
22. D'Ambrosio D., Sinigaglia F., Adorini L. Special attractions for suppressor T cells. Trends Immunol. 24(3):2003;122-126
23. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nature Rev. Immunol. 2(3):2002;151-161
24. Penna G., Vulcano M., Roncari A., Facchetti F., Sozzani S., Adorini L. Differential chemokine production by myeloid and plasmacytoid dendritic cells. J. Immunol. 169:2002;6673-6676
25. 3 analog enhances regulatory T cells and arrests autoimmune diabetes in NOD mice. Diabetes. 51:2002;1367-1374
26. Barrat F.J., Cua D.J., Boonstra A., Richards D.F., Crain C., Savelkoul H.F., de Waal-Malefyt R., Coffman R.L., Hawrylowicz C.M., O'Garra A. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195(5):2002;603-616
27. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E., Roncarolo M.G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389(6652):1997;737-742
28. D'Ambrosio D., Cippitelli M., Cocciolo M.G., Mazzeo D., Di Lucia P., Lang R., Sinigaglia F., Panina-Bordignon P. Inhibition of IL-12 production by 1, 25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest. 101(1):1998;252-262
29. Nagpal S., Lu J., Boehm M.F. Vitamin D analogs: mechanism of action and therapeutic applications. Curr. Med. Chem. 8(13):2001;1679-1697
30. Brown A.J. Therapeutic uses of vitamin D analogues. Am. J. Kidney Dis. 38(5 Suppl 5):2001;S3-S19
31. Adorini L. 1, 25-Dihydroxyvitamin D3 analogs as potential therapies in transplantation. Curr. Opin. Investig. Drugs. 3(10):2002;1458-1463
32. Rochel N., Wurtz J.M., Mitschler A., Klaholz B., Moras D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell. 5(1):2000;173-179
33. Casteels K., Waer M., Laureys J., Valckx D., Depovere J., Bouillon R., Mathieu C. Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine. Transplantation. 65(9):1998;1225-1232
34. Mattner F., Smiroldo S., Galbiati F., Muller M., Di Lucia P., Poliani P.L., Martino G., Panina-Bordignon P., Adorini L. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1, 25-dihydroxyvitamin D3. Eur. J. Immunol. 30(2):2000;498-508
35. van Etten E., Branisteanu D.D., Verstuyf A., Waer M., Bouillon R., Mathieu C. Analogs of 1, 25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants. Transplantation. 69(9):2000;1932-1942
36. Raisanen-Sokolowski A.K., Pakkala I.S., Samila S.P., Binderup L., Hayry P.J., Pakkala S.T. A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts. Transplantation. 63(7):1997;936-941
37. Kallio E., Hayry P., Pakkala S. MC1288, a vitamin D analogue, reduces short- and long-term renal allograft rejection in the rat. Transplant. Proc. 28(6):1996;3113
38. Aschenbrenner J., Hullett D., Heisey D., Pirsch J., Sollinger H., Becker B. 1, 25-dihydroxyvitamin D3 (1, 25(OH)2D3) has salutary effects on renal allograft function. Transplantation. 69:2000;S448
39. Allison A.C., Eugui E.M. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin. Transplant. 10(1 Pt 2):1996;77-84
40. Mehling A., Grabbe S., Voskort M., Schwarz T., Luger T.A., Beissert S. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. J. Immunol. 165(5):2000;2374-2381
41. Lu L., Thomson A.W. Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease. Transplantation. 73(1 Suppl):2002;S19-S22
42. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193:2001;233-238
43. Alroy I., Towers T., Freedman L. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 15:1995;5789-5799
44. 3-mediated effects. J. Immunol. 160:1998;209-218
45. 3: a transcriptional modulator of the IFN-γ gene. Eur. J. Immunol. 28:1998;3017-3030
46. Redaelli C.A., Wagner M., Gunter-Duwe D., Tian Y.H., Stahel P.F., Mazzucchelli L., Schmid R.A., Schilling M.K. 1alpha, 25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants. Kidney Int. 61(1):2002;288-296
47. Aschenbrenner J.K., Sollinger H.W., Becker B.N., Hullett D.A. 1, 25-OH(2)D(3) alters the transforming growth factor beta signaling pathway in renal tissue. J. Surg. Res. 100(2):2001;171-175
48. Vulcano M., Struyf S., Scapini P., Cassatella M., Bernasconi S., Bonecchi R., Calleri A., Penna G., Adorini L., Luini W., Mantovani A., Van Damme J., Sozzani S. Unique regulation of CCL18 production by maturing dendritic cells. J. Immunol. 170(7):2003;3843-3849